메뉴 건너뛰기




Volumn 14, Issue 1, 2015, Pages

A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia

Author keywords

Fasting plasma glucose; Glycoalbumin; HbA1c; Japanese; LDL C

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CHOLESTEROL; CREATINE KINASE; CREATININE; EZETIMIBE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLYCOALBUMIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; POTASSIUM; PROTEIN; SODIUM; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED SERUM ALBUMIN; HEMOGLOBIN A1C PROTEIN, HUMAN; HYPOCHOLESTEROLEMIC AGENT; SERUM ALBUMIN;

EID: 84930002972     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0036-z     Document Type: Article
Times cited : (17)

References (37)
  • 1
    • 0024223817 scopus 로고
    • The Prospective Cardiovascular Munster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease
    • 1:STN:280:DyaL1M%2FnsVGhuw%3D%3D 3202078
    • Assmann G, Schulte H. The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J. 1988;116:1713-24.
    • (1988) Am Heart J , vol.116 , pp. 1713-1724
    • Assmann, G.1    Schulte, H.2
  • 2
    • 33344471035 scopus 로고    scopus 로고
    • Effect of pravastatin and atorvastatin on glucose metabolism in nondiabetic patients with hypercholesterolemia
    • 16484739
    • Ishikawa M, Namiki A, Kubota T, Yajima S, Fukazawa M, Moroi M, et al. Effect of pravastatin and atorvastatin on glucose metabolism in nondiabetic patients with hypercholesterolemia. Intern Med. 2006;45:51-5.
    • (2006) Intern Med , vol.45 , pp. 51-55
    • Ishikawa, M.1    Namiki, A.2    Kubota, T.3    Yajima, S.4    Fukazawa, M.5    Moroi, M.6
  • 3
    • 77949300393 scopus 로고    scopus 로고
    • Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients
    • 3016087 1:CAS:528:DC%2BC3cXpvFSqurc%3D 20298928
    • Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Shin EK. Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol. 2010;55:1209-16.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1209-1216
    • Koh, K.K.1    Quon, M.J.2    Han, S.H.3    Lee, Y.4    Kim, S.J.5    Shin, E.K.6
  • 4
    • 56749106312 scopus 로고    scopus 로고
    • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    • 1:CAS:528:DC%2BD1cXhtl2gurnL 18997196
    • Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto Jr AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-207.
    • (2008) N Engl J Med , vol.359 , pp. 2195-2207
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3    Genest, J.4    Gotto, Jr.A.M.5    Kastelein, J.J.6
  • 5
    • 77549087054 scopus 로고    scopus 로고
    • Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
    • 1:CAS:528:DC%2BC3cXisFart74%3D 20167359
    • Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375:735-42.
    • (2010) Lancet , vol.375 , pp. 735-742
    • Sattar, N.1    Preiss, D.2    Murray, H.M.3    Welsh, P.4    Buckley, B.M.5    De Craen, A.J.6
  • 6
    • 84875065352 scopus 로고    scopus 로고
    • Statins and risk of treated incident diabetes in a primary care population
    • 3612730 1:CAS:528:DC%2BC3sXktFOgsbg%3D 22845189
    • Zaharan NL, Williams D, Bennett K. Statins and risk of treated incident diabetes in a primary care population. Br J Clin Pharmacol. 2013;75:1118-24.
    • (2013) Br J Clin Pharmacol , vol.75 , pp. 1118-1124
    • Zaharan, N.L.1    Williams, D.2    Bennett, K.3
  • 7
    • 84921534753 scopus 로고    scopus 로고
    • How to balance cardiorenometabolic benefits and risks of statins
    • 1:CAS:528:DC%2BC2cXhtFCiurbP 24973595
    • Lim S, Oh PC, Sakuma I, Koh KK. How to balance cardiorenometabolic benefits and risks of statins. Atherosclerosis. 2014;235:644-8.
    • (2014) Atherosclerosis , vol.235 , pp. 644-648
    • Lim, S.1    Oh, P.C.2    Sakuma, I.3    Koh, K.K.4
  • 8
    • 79959428660 scopus 로고    scopus 로고
    • Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: A meta-analysis
    • 1:CAS:528:DC%2BC3MXotVantLs%3D 21693744
    • Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011;305:2556-64.
    • (2011) JAMA , vol.305 , pp. 2556-2564
    • Preiss, D.1    Seshasai, S.R.2    Welsh, P.3    Murphy, S.A.4    Ho, J.E.5    Waters, D.D.6
  • 10
    • 33845872811 scopus 로고    scopus 로고
    • In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs
    • 1:CAS:528:DC%2BD2sXit1Gktw%3D%3D 17005902
    • Hawes BE, O'Neill KA, Yao X, Crona JH, Davis Jr HR, Graziano MP, et al. In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs. Mol Pharmacol. 2007;71:19-29.
    • (2007) Mol Pharmacol , vol.71 , pp. 19-29
    • Hawes, B.E.1    O'Neill, K.A.2    Yao, X.3    Crona, J.H.4    Davis, Jr.H.R.5    Graziano, M.P.6
  • 11
    • 37249049393 scopus 로고    scopus 로고
    • The effects of high dose pravastatin and low dose pravastatin and ezetimibe combination therapy on lipid, glucose metabolism and inflammation
    • 1:CAS:528:DC%2BD2sXhsVaisrrM 17687635
    • Dagli N, Yavuzkir M, Karaca I. The effects of high dose pravastatin and low dose pravastatin and ezetimibe combination therapy on lipid, glucose metabolism and inflammation. Inflammation. 2007;30:230-5.
    • (2007) Inflammation , vol.30 , pp. 230-235
    • Dagli, N.1    Yavuzkir, M.2    Karaca, I.3
  • 12
    • 84863554957 scopus 로고    scopus 로고
    • Ezetimibe ameliorates atherosclerotic and inflammatory markers, atherogenic lipid profiles, insulin sensitivity, and liver dysfunction in Japanese patients with hypercholesterolemia
    • 1:CAS:528:DC%2BC38XhtlGgtrrL 22353686
    • Tamaki N, Ueno H, Morinaga Y, Shiiya T, Nakazato M. Ezetimibe ameliorates atherosclerotic and inflammatory markers, atherogenic lipid profiles, insulin sensitivity, and liver dysfunction in Japanese patients with hypercholesterolemia. J Atheroscler Thromb. 2012;19:532-8.
    • (2012) J Atheroscler Thromb , vol.19 , pp. 532-538
    • Tamaki, N.1    Ueno, H.2    Morinaga, Y.3    Shiiya, T.4    Nakazato, M.5
  • 13
    • 77649196152 scopus 로고    scopus 로고
    • Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia
    • 1:CAS:528:DC%2BC3MXhvVeru70%3D 20150722
    • Yagi S, Akaike M, Aihara K, Iwase T, Ishikawa K, Yoshida S, et al. Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia. J Atheroscler Thromb. 2010;17:173-80.
    • (2010) J Atheroscler Thromb , vol.17 , pp. 173-180
    • Yagi, S.1    Akaike, M.2    Aihara, K.3    Iwase, T.4    Ishikawa, K.5    Yoshida, S.6
  • 15
    • 84871738435 scopus 로고    scopus 로고
    • Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia
    • 1:CAS:528:DC%2BC3sXjsFGntb8%3D 22878697
    • Kikuchi K, Nezu U, Inazumi K, Miyazaki T, Ono K, Orime K, et al. Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia. J Atheroscler Thromb. 2012;19:1093-101.
    • (2012) J Atheroscler Thromb , vol.19 , pp. 1093-1101
    • Kikuchi, K.1    Nezu, U.2    Inazumi, K.3    Miyazaki, T.4    Ono, K.5    Orime, K.6
  • 16
    • 79951924395 scopus 로고    scopus 로고
    • Efficacy of ezetimibe as monotherapy or combination therapy in hypercholesterolemic patients with and without diabetes
    • 21372492
    • Kishimoto M, Sugiyama T, Osame K, Takarabe D, Okamoto M, Noda M. Efficacy of ezetimibe as monotherapy or combination therapy in hypercholesterolemic patients with and without diabetes. J Med Invest. 2011;58:86-94.
    • (2011) J Med Invest , vol.58 , pp. 86-94
    • Kishimoto, M.1    Sugiyama, T.2    Osame, K.3    Takarabe, D.4    Okamoto, M.5    Noda, M.6
  • 17
    • 84930010035 scopus 로고    scopus 로고
    • Changes in Fasting Glucose Levels Following Longer-term Treatment with Simvastatin Monotherapy and Combined Ezetimibe + Simvastatin [abstract]
    • Toth PP, Catapano A, Farnier M, Foody J, Tomassini JE, Jensen E, et al. Changes in Fasting Glucose Levels Following Longer-term Treatment with Simvastatin Monotherapy and Combined Ezetimibe + Simvastatin [abstract]. JACC. 2014;63:A1313.
    • (2014) JACC , vol.63 , pp. 1313
    • Toth, P.P.1    Catapano, A.2    Farnier, M.3    Foody, J.4    Tomassini, J.E.5    Jensen, E.6
  • 18
    • 84929999960 scopus 로고    scopus 로고
    • Effects of Ezetimibe, Ezetimibe Coadministered with Statins and Statin Therapies on Fasting Glucose Changes in Patients with Hypercholesterolemia [abstract]
    • Toth PP, Catapano A, Farnier M, Foody J, Tomassini JE, Jensen E, et al. Effects of Ezetimibe, Ezetimibe Coadministered with Statins and Statin Therapies on Fasting Glucose Changes in Patients with Hypercholesterolemia [abstract]. J Clin Lipidol. 2013;7:277.
    • (2013) J Clin Lipidol , vol.7 , pp. 277
    • Toth, P.P.1    Catapano, A.2    Farnier, M.3    Foody, J.4    Tomassini, J.E.5    Jensen, E.6
  • 20
    • 67649397411 scopus 로고    scopus 로고
    • Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study)
    • 1:CAS:528:DC%2BD1MXnsV2rsrs%3D 19539078
    • Robinson JG, Ballantyne CM, Grundy SM, Hsueh WA, Parving HH, Rosen JB, et al. Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study). Am J Cardiol. 2009;103:1694-702.
    • (2009) Am J Cardiol , vol.103 , pp. 1694-1702
    • Robinson, J.G.1    Ballantyne, C.M.2    Grundy, S.M.3    Hsueh, W.A.4    Parving, H.H.5    Rosen, J.B.6
  • 21
    • 84855195518 scopus 로고    scopus 로고
    • Atorvastatin 10 mg plus ezetimibe 10 mg compared with atorvastatin 20 mg: Impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease
    • 22100058
    • Uemura Y, Watarai M, Ishii H, Koyasu M, Takemoto K, Yoshikawa D, et al. Atorvastatin 10 mg plus ezetimibe 10 mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease. J Cardiol. 2012;59:50-6.
    • (2012) J Cardiol , vol.59 , pp. 50-56
    • Uemura, Y.1    Watarai, M.2    Ishii, H.3    Koyasu, M.4    Takemoto, K.5    Yoshikawa, D.6
  • 22
    • 57349106472 scopus 로고    scopus 로고
    • Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice
    • 2575916 1:CAS:528:DC%2BD1cXht1ymtbvN 18718999
    • Labonte ED, Camarota LM, Rojas JC, Jandacek RJ, Gilham DE, Davies JP, et al. Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice. Am J Physiol Gastrointest Liver Physiol. 2008;295:G776-83.
    • (2008) Am J Physiol Gastrointest Liver Physiol , vol.295 , pp. 776-783
    • Labonte, E.D.1    Camarota, L.M.2    Rojas, J.C.3    Jandacek, R.J.4    Gilham, D.E.5    Davies, J.P.6
  • 23
    • 36549013633 scopus 로고    scopus 로고
    • Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome
    • 1:CAS:528:DC%2BD2sXhtlykt7vM 18022391
    • Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, Okazaki M, et al. Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett. 2007;581:5664-70.
    • (2007) FEBS Lett , vol.581 , pp. 5664-5670
    • Deushi, M.1    Nomura, M.2    Kawakami, A.3    Haraguchi, M.4    Ito, M.5    Okazaki, M.6
  • 24
    • 84869034578 scopus 로고    scopus 로고
    • Effect of ezetimibe on insulin secretion in db/db diabetic mice
    • 3483710 23118741
    • Zhong Y, Wang J, Gu P, Shao J, Lu B, Jiang S. Effect of ezetimibe on insulin secretion in db/db diabetic mice. Exp Diabetes Res. 2012;2012:420854.
    • (2012) Exp Diabetes Res , vol.2012 , pp. 420854
    • Zhong, Y.1    Wang, J.2    Gu, P.3    Shao, J.4    Lu, B.5    Jiang, S.6
  • 25
    • 84876724789 scopus 로고    scopus 로고
    • Effects of ezetimibe on atherogenic lipoproteins and glucose metabolism in patients with diabetes and glucose intolerance
    • 1:CAS:528:DC%2BC3sXhvFShurs%3D 23369229
    • Tsunoda T, Nozue T, Yamada M, Mizuguchi I, Sasaki M, Michishita I. Effects of ezetimibe on atherogenic lipoproteins and glucose metabolism in patients with diabetes and glucose intolerance. Diabetes Res Clin Pract. 2013;100:46-52.
    • (2013) Diabetes Res Clin Pract , vol.100 , pp. 46-52
    • Tsunoda, T.1    Nozue, T.2    Yamada, M.3    Mizuguchi, I.4    Sasaki, M.5    Michishita, I.6
  • 26
    • 0037504445 scopus 로고    scopus 로고
    • Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial
    • 1:CAS:528:DC%2BD3sXjs1antLY%3D 12719279
    • Ballantyne CM, Houri J, Notarbartolo A, Melani L, Lipka LJ, Suresh R, et al. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Circulation. 2003;107:2409-15.
    • (2003) Circulation , vol.107 , pp. 2409-2415
    • Ballantyne, C.M.1    Houri, J.2    Notarbartolo, A.3    Melani, L.4    Lipka, L.J.5    Suresh, R.6
  • 27
    • 11844291388 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia
    • 1:CAS:528:DC%2BD2MXotFaktQ%3D%3D 15639688
    • Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, et al. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia. Clin Ther. 2004;26:1758-73.
    • (2004) Clin Ther , vol.26 , pp. 1758-1773
    • Bays, H.E.1    Ose, L.2    Fraser, N.3    Tribble, D.L.4    Quinto, K.5    Reyes, R.6
  • 28
    • 0037132598 scopus 로고    scopus 로고
    • Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia
    • 1:CAS:528:DC%2BD3sXltFyrtg%3D%3D 12505224
    • Davidson MH, McGarry T, Bettis R, Melani L, Lipka LJ, LeBeaut AP, et al. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. J Am Coll Cardiol. 2002;40:2125-34.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 2125-2134
    • Davidson, M.H.1    McGarry, T.2    Bettis, R.3    Melani, L.4    Lipka, L.J.5    Lebeaut, A.P.6
  • 29
    • 0037111924 scopus 로고    scopus 로고
    • Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia
    • 1:CAS:528:DC%2BD38Xotl2mt7s%3D 12423709
    • Dujovne CA, Ettinger MP, McNeer JF, Lipka LJ, LeBeaut AP, Suresh R, et al. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol. 2002;90:1092-7.
    • (2002) Am J Cardiol , vol.90 , pp. 1092-1097
    • Dujovne, C.A.1    Ettinger, M.P.2    McNeer, J.F.3    Lipka, L.J.4    Lebeaut, A.P.5    Suresh, R.6
  • 30
    • 2342574933 scopus 로고    scopus 로고
    • Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: A randomized, double-blind, placebo-controlled trial
    • 1:CAS:528:DC%2BD2cXksVWhsr4%3D 15132403
    • Goldberg AC, Sapre A, Liu J, Capece R, Mitchel YB. Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc. 2004;79:620-9.
    • (2004) Mayo Clin Proc , vol.79 , pp. 620-629
    • Goldberg, A.C.1    Sapre, A.2    Liu, J.3    Capece, R.4    Mitchel, Y.B.5
  • 31
    • 0037441702 scopus 로고    scopus 로고
    • Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia
    • 1:CAS:528:DC%2BD3sXhtVGntLg%3D 12586255
    • Kerzner B, Corbelli J, Sharp S, Lipka LJ, Melani L, LeBeaut A, et al. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia. Am J Cardiol. 2003;91:418-24.
    • (2003) Am J Cardiol , vol.91 , pp. 418-424
    • Kerzner, B.1    Corbelli, J.2    Sharp, S.3    Lipka, L.J.4    Melani, L.5    Lebeaut, A.6
  • 32
    • 0037395141 scopus 로고    scopus 로고
    • Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia
    • 1:CAS:528:DC%2BD3sXjtFWmsrY%3D 12713767
    • Knopp RH, Gitter H, Truitt T, Bays H, Manion CV, Lipka LJ, et al. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J. 2003;24:729-41.
    • (2003) Eur Heart J , vol.24 , pp. 729-741
    • Knopp, R.H.1    Gitter, H.2    Truitt, T.3    Bays, H.4    Manion, C.V.5    Lipka, L.J.6
  • 33
    • 0344490262 scopus 로고    scopus 로고
    • Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial
    • 1:CAS:528:DC%2BD3sXjtFWmsrk%3D 12713766
    • Melani L, Mills R, Hassman D, Lipetz R, Lipka L, LeBeaut A, et al. Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Eur Heart J. 2003;24:717-28.
    • (2003) Eur Heart J , vol.24 , pp. 717-728
    • Melani, L.1    Mills, R.2    Hassman, D.3    Lipetz, R.4    Lipka, L.5    Lebeaut, A.6
  • 34
    • 64249120001 scopus 로고    scopus 로고
    • Ezetimibe monotherapy for cholesterol lowering in 2,722 people: Systematic review and meta-analysis of randomized controlled trials
    • 1:CAS:528:DC%2BD1MXlvFOit7k%3D 19141093
    • Pandor A, Ara RM, Tumur I, Wilkinson AJ, Paisley S, Duenas A, et al. Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials. J Intern Med. 2009;265:568-80.
    • (2009) J Intern Med , vol.265 , pp. 568-580
    • Pandor, A.1    Ara, R.M.2    Tumur, I.3    Wilkinson, A.J.4    Paisley, S.5    Duenas, A.6
  • 35
    • 84905040766 scopus 로고    scopus 로고
    • Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population
    • 1:CAS:528:DC%2BC2cXpvFWmu7s%3D 25066560
    • Blazing MA, Giugliano RP, Cannon CP, Musliner TA, Tershakovec AM, White JA, et al. Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population. Am Heart J. 2014;168:205-12.
    • (2014) Am Heart J , vol.168 , pp. 205-212
    • Blazing, M.A.1    Giugliano, R.P.2    Cannon, C.P.3    Musliner, T.A.4    Tershakovec, A.M.5    White, J.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.